Maha Meshal Abdullah AlRasheed

 

Contact
P.O. Box 7038	Riyadh 11462
E-mail: mahalrasheed@ksu.edu.sa	Saudi Arabia

 

Biography

Dr. Maha is an associate professor of pharmacogenomics at the clinical pharmacy department, college of pharmacy, King Saud University. She has a Master’s degree in clinical pharmacy from King Saud University and eventually earned her Ph.D. in pharmacogenomics from the University of Brighton, U.K. Her dissertation entitled “Association of Gene Polymorphisms in Thyroid Function-related Genes with Differentiated Thyroid Cancer Risk and Post Thyroidectomy L-Thyroxine Suppressive Dose Requirements” was primarily addressed to personalized medicine, population genetics, association studies and complex disorders. Dr. Maha was assigned deputy chair of the clinical pharmacy department at the college of pharmacy at King Saud University from 2015-2017. Currently, she is the assistant of the vice rector for projects for girls at King Saud University.  Through with scientists at King Faisal research center as a visiting research associate in the genetics department, Dr. Maha has extended her previous work in order to address analysis and processing of genetic factors for patients setting that are needed to diagnose, treat, prevent and cure many illnesses. Dr. Maha’s primary research interests are genetics and pharmacogenomics, family and population genetics; Personalized medicine; Mendelian diseases; Genome sequencing and annotation; and association studies in cardiovascular disease, cancers and endocrinology.  Dr. Maha received many awards from International and local conferences. Currently, she is supervising two Ph.D. students at the University College of London and New Castle University. In addition, she is supervising Master and PharmD students at King Saud University and Riyadh Alelm University.

 

 

EDUCATION:

December 17th, 2013:                           PhD in Pharmacogenomics, PHARMACY AND BIOMOLECULAR SCIENCES, University of Brighton, United Kingdom

Dissertation:                                       Association of Gene Polymorphisms in Thyroid Function-related Genes with Differentiated Thyroid Cancer Risk and Post Thyroidectomy L-Thyroxine Suppressive Dose Requirements

July 7th, 2011:                                      Master of Philosophy in Pharmacogenomics, PHARMACY AND BIOMOLECULAR SCIENCES, University of Brighton, United Kingdom

Thesis: The role of gene polymorphism in the etiology of differentiated thyroid cancer and L-thyroxin dose requirement in athyrotic patients

1997-2000:                                           MSc in Clinical Pharmacy from King Saud University in Riyadh, Saudi Arabia, GPA 4.6/5   

Thesis:                                                 Pharmacokinetics of ketoprofen: A comparative study in presence and absence of pethidine after surgery  

1991-1996:                                           BSc in pharmacy from King Saud University in Riyadh, Saudi Arabia. GPA 4.55/5

 

PROFESSIONAL APPOINTMENTS:

2022- Present                        Advisor of H.E. President of Princess Nourah Bint Abdulrahman University, .

2020, December-present                      Associate professor of pharmacogenetics, Clinical pharmacy department, KSU, Saudi Arabia

2018, October- 2022                       Assistant of the Vice Rector for Projects for Girls

2017, October- 2018, October             Advisor of the Vice Rector for Projects for Girls

2017- present                                       Chair- Pharmacy Research Day- College of Pharmacy, KSU

2016, October – 2017, October            Advisor of the Vice Rector for Projects for Safety and Security for Girls

2015, August 18- 2017, September      Deputy Chair, Clinical Pharmacy Department, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

2014, November-Present                     Assistant professor of pharmacogenetics, Clinical pharmacy department, KSU, Saudi Arabia

2008-2017                                            Adjunct appointment as a Visiting Research Associate in the Genetic department at the Research Center, King Faisal Specialist Hospital and Research Center (KFSH & RC)

1997-2008 &2014-present.                   Students’ Advisor for undergraduate students, Department of Clinical Pharmacy, College of Pharmacy, King Saud University.1998-2008

 

PROFESSIONAL EXPERIENCES:

2020, December-present:                    Associate professor of pharmacogenetics, Clinical pharmacy department, KSU, Saudi Arabia

2017- present:                                     Chairperson, College of Pharmacy Research Day. College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

2015- 2017:                                         Deputy Chair, Clinical Pharmacy Department, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

2015- 2017:                                         Chairperson, Pharm.D. Internship Research Day. College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

2015, February:                                  7th Judge, the Sixth Scientific Meeting. King Saud University, Riyadh, Saudi Arabia

2014, November-Present:                    Assistant professor, Clinical pharmacy department, KSU, Saudi Arabia

2014, April- Present:                           Lecturing at College of Pharmacy, King Saud University, Saudi Arabia

2009, June14:                                      The Research Processes and Methodologies course, PHARMACY AND BIOMOLECULAR SCIENCES, University of Brighton, United Kingdom

2008-present:                                      Adjunct appointment as a Visiting Research Associate in the Genetic department at the Research Center, King Faisal Specialist Hospital and Research Center (KFSH & RC)

2006-2009:                                          Member of the Education & Public Awareness Committee, Saudi Food and Drug Authority

2005-2008:                                          Member of Establishment Committee, Saudi Clinical Pharmacy Club

2006- 2008:                                         Preceptor for undergraduate pharmacy students in the clinical clerkship rotation at the Endocrinology services.

2005-2008:                                          Clinical pharmacist in the medical Endocrinology department in the King Khalid University Hospital.

2003-2004:                                          Member of the Preparation Team of TV. Program, Society and Medication Program, Channel 2, Saudi Television

2001-2014:                                          Lecturer in the department of Clinical Pharmacy, in The School of Pharmacy, At King Saud University, Riyadh, Saudi Arabia.

Courses:Clerkship, Therapeutics, Pharmacoepidemiology, Clinical Pharmacokinetics, Advance Drug Information, and Pharmacy Law

Jan 2000:                                            King Khalid University Hospital:  Cardiovascular Rotation. Preceptor: Dr.H. Zaghloul

Dec 1999:                                            King Khalid University Hospital:  Pharmacokinetic Rotation. Preceptor: Dr.J.Kaka Pharm.D·

Nov 1999:                                            King Khalid University Hospital: Gastroenterology Rotation. Preceptor: Dr.Mayet Pharm.D·

Oct 1999:                                            King Khalid University Hospital: Infectious disease Rotation. Preceptor: Dr A.Alghasham. Pharm.D·

Sep 1999:                                            King Khalid University Hospital: Drug Information Rotation · Preceptor: Dr. A.Alghasham. Pharm.D·  

June 1999:                                          King Khalid University Hospital: In patient Pharmacy Rotation · Preceptor: Dr.A. Alduwailea

1996-2001:                                          Teaching assistant in the department of Clinical Pharmacy, The School of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

 

COMMITTEES:

 

2020-present:                                      Member, the scientific committee for research grants initiative Corona “COVID 19”, Ministry of Health, Saudi Arabia

2019- present:                                     Member of the Standing Committee to consider matters related to university employees

2019-present:                                      Member, the sub-committee of the University Rectorate for Projects to consider the applications received by the affiliated departments for flexible working hours

2019-2020:                                          Member, Founding Committee, Molecular Biology Interdisciplinary Program, College of Science, King Saud University

2018-present:                                      Head, Pharmacy research day advisory committee, College of pharmacy, KSU

2018-present:                                      Head, , Pharmacy research projects committee, College of pharmacy, KSU

2017-present:                                      Head, University space allocation  committee, KSU

2017-present:                                      Member, University investment  committee, KSU

2017-present:                                      Member, University graduation ceremony committee, KSU

2017-present:                                      Member, Coordinating council, female student campus (Olaysha), King Saud University

2017-present:                                      Head, Pharmacy Research Day committee, College of pharmacy, KSU

2017-present:                                      Rapporteur, Pharmacy Research Day Organizing Committee, College of Pharmacy, KSU

2017-present:                                      Member, Pharmacy Research Day Advisory Committee, College of Pharmacy, KSU

2016-present:                                      Coordinating council, female student campus (Derayah), King Saud University

2016- present:                                     Member, students’ disciplinary committee, King Saud University, Riyadh, Saudi Arabia

2016-present:                                      Member, PhD committee, Clinical pharmacy department, KSU

2015-present:                                      Member, Central Examination Unit, College of Pharmacy, KSU

2015-present:                                      Member, Teaching assistants interview committee, College of Pharmacy, KSU

2015-2017:                                          Postgraduates applicant’s committee, Clinical pharmacy department, KSU

2015-2017:                                          Chair, Research Day Committee, Clinical pharmacy department, KSU

2014-2015:                                          Member. Scientific research committee, College of Pharmacy, KSU

2005-2008:                                          Editor, “Pharmacy Spotlight newsletter” published by the College of Pharmacy, King Saud University.

2004-2009:                                          Member of the Drug and Poison Information committee, College of Pharmacy, King Saud University

1999-2001:                                          Member of the “Environment Protection Week” committee, College of Pharmacy, King Saud University.

1998 – 2000:                                        Member of the “University and Society Week” committee, College of Pharmacy, King Saud University.

 

ACADEMIC SUPERVISION:

 

PhD degree:

1. Student: Salha Jokhab.

December 2015- Present.

University: New Castle University, New Castle, UK

 

2. Student: Ghada Ibrahim Aboheimed                                                                                                          August 2015- Present.

University: University College of London, London, UK

 

Master degree:

1. Student: Hanouf Altheeb, KSU, Riyadh

2019: Screening of ataxia samples reveals a novel compound heterozygous mutation and a founder mutation in ATM   

2. Student: Wajed Alshamari, Riyadh Alelm University, Riyadh.

2019: Development of deprescribing algorithm to improve patient quality use of medication

3. Student: Hadeel Jaber, KSU, Riyadh

2017: Identification of a Mutation Responsible for Autosomal Recessive Cerebellar Ataxia in a Saudi Family

4. Student: Alanoud Alanazi, KSU, Riyadh

2016: Knowledge and Willingness of Physicians about Deprescribing Among Older Saudi Patients: A Qualitative Study

5. Student: Sara Khalid Alqahtani, KSU, Riyadh

2016: Patients’ knowledge of and willingness to Vaccination through Community Pharmacy among adults in Saudi Arabia

6. Student: Lina Aljawhari, KSU, Riyadh

2015: NPHS1 and NPHS2 Mutations in Patients with Congenital Nephrosis 

7. Student: Badreya Alotaibi, KSU, Riyadh

2003: Effect of aminoglycoside dosing on magnesium levels in hospitalized patients

8. Student: Jamilah Al-Saeedan, KSU,Riyadh

2003: Bone Mineral Density Measurements and Risk Factor Assessment for Osteoporosis in Young Healthy Saudi Female

Undergraduate Students:

1. Students: Amani Alshahrani and Sara Almuhaini 2020: Study entitled “Knowledge, Attitude and Practice of Healthcare Workers Towards the Novel Coronavirus (COVID-19) pandemic: A Cross-Sectional Study”.
2. Students: Afnan Alqudair and Khloud Alshgairan 2020: Study entitled “The impact of quarantine on sleep quality and psychological distress during the COVID-19 pandemic in Saudi Arabia”.
3. Stude Students: Hala Almarzougi and Ghada Alenzi 2020: Study entitled “Assessment of Knowledge, Attitude and Practice of Security and Safety Workers towards COVID-19: A Cross-Sectional Study”.
4. Students: Maysa Alfuraih and Aishah Alnafeesah 2019 January: Study entitled “Genetic of MS”.
5. Students: Afnan Alrasheed and Shoug Alharbi. 2019 January: Study entitled “Genetic of neurological disorder”.
6. Students: Abdulrahman Alsuwaid and Suhail Alkhalaf. 2018 April: Study entitled “Knowledge and Attitude of Healthcare Professional Towards Gene Therapy: A Cross-Sectional Study”.
7. Students: Ashwaq AlAnzi and Rawan AlShalhoub. 2018 February: Study entitled “The Potential Role of DIO1, DIO2 and TSHβ Polymorphisms in the Development of Differentiated Thyroid Cancer and L-Thyroxine Dose Requirements”.
8. Students: Ashwag al-yousef, Lama Aldawsari.2018 February: Study entitled “Whole Exome Sequencing Identifies Novel Gene Associated with Hereditary Spastic Paraplegias Among Saudi Patients”.
9. Students: Nora Alkhayyat and Taghreed Alzahrani. 2017 February: Study entitled “A Novel ETFB Mutation in Saudi Adult with Glutaric Aciduria Type II: A Case report”.
10. Students: Hissah Al-Mohaini, Hanan Abouzaid. 2017 February: Study entitled “The Role of KCNQ1 and AKAP9 as Genetic Modifier of Congenital Long-QT Syndrome”.
11. Students: Khawla Alaseri and Reem Bamogaddam. 2016 February: Study entitled “Mutation Identification in ACADVL Gene in very long chain acyl co A dehydrogenase deficiency patients”.
12. Students: Nourhan Elsherif and Ment Allah Hefnawy. 2016 February: Study entitled “Association of gene polymorphism in CDKN2B and CDKN2A gene and coronary heart disease”.
13. Students: Nourah Alshaikh, Latifah Aldekan and Lama Alharabi. 2016 February: Study entitled “Identification of mutation in GAA gene in Saudi patients with Glycogen storage disease type II”.
14. Students: Ghadah alrashidi,  Nouf albishi, Wafa alsolami. 2015 February-May 2016:  Study entitled” Clinical and Molecular Characterization of Patients with Jervell & Lange-Nielsen Syndrome in Saudi Patients”.
15. Students: Burouj AlQahtani , Hadeel alharbi, Rawan Almadhi, Senaa Alnajrani. 2015 February-May 2016: Study entitled “Association of gene polymorphisms in PAX8 GENE with differentiated thyroid cancer risk”.
16. Students: Asma Alfarhan,Rana Almohaimeed . 2015 February-May 2016: Study entitled “Mutation Identification in DOLK Gene in Saudi Patients with Dilated Cardiomyopathy”.
17. Students: Alaa Assiri, Abeer Altaweel, Albatool Bin Ajlan, Rawan Almugbel, and Shaikha     Aldukhail. 2015, February-June: Study entitled “Synergistic Effect of Omega-3 Fatty Acid and Aloe Vera Oil on Improving Skin Elasticity and Thickness: A Randomized-Double Blind Controlled Study”.
18. Students: Mashael Alrubaishi and Alanoud Aleid. 2014 April – 2015 June:  Study entitled “Genetic Analysis of Bartter’s and Gitelman’s Syndromes in Saudi Patients”.

 

COMMUNITY SERVICES:

 

 

2020 October-February:                     Contribute in (Oral Biology and Genetics) lectures- The Saudi Board for Oral Medicine and Pathology

2019, April:                                         Meet the National Commission for Academic Accreditation and Assessment (NCAAA) team to discuss the Research at college of pharmacy session, college of pharmacy, KSU

2018-2019:                                          Organize and chair “The 8th and 9th College of pharmacy Research Day”, College of pharmacy, KSU

July 2018:                                           Participate, prepare and present Princess Noura Bint Abdulrahman University board of trustee establishment proposal, KSU and PNU

October 11-13, 2018:                           Establish and organize “The foundation course in clinical medication management-update in therapeutics 2018”, in collaboration of Deanship of skills and development and Medication Safety Research Chair, KSU

4-5 April 2018:                                    Member in the organizing team of the first conference of National observatory for women, Women empowerment-KSU

2017- present:                                     Member in the organizing team of KSU girls graduation ceremony, KSU

2017- present:                                     Head of the evacuation plan girls committee, Vice president for projects, KSU

2017- present:                                     Head of the educational safety and security corner under Vice president for projects, preparatory week, KSU

April 11, 2017:                                    Participate in the third medication safety chair week by presenting “Pharmacogenomics and medication safety: Personalized medicine”, KSU

2015-2017:                                          Establish, organize and chair “first, second and third PharmD internship Research Day”, Clinical pharmacy department, College of pharmacy, KSU

October 2016:                                     Participate in the preparation of Pharmacy-Based Immunization Delivery booklet and program, Ministry of Health

2015, February 7th:                             Judge, The Sixth Scientific Meeting. King Saud University, Riyadh, Saudi Arabia

April 2016:                                          Participate in pharmacy student’s competition, college of pharmacy annual gathering (girls section), college of pharmacy, King Saud University, Riyadh, Saudi Arabia

December 3, 2014:                              Supervise and arrange for “Commit to be fit” campaign, College of Pharmacy, King Saud University, Saudi Arabia

October-December,2014:                    Supervise and arrange for weekly seminars presented by Master students as part of 591PHCL course in KKUH as part of the Pharmacy activity to all staff. KKUH, Saudi Arabia

October-December,2014:                    Supervise and arrange for weekly seminars presented by Master students as part of 590PHCL course in College of Pharmacy as part of the course activity. College of Pharmacy, KSU, Saudi Arabia

May 5-10,2009:                                   Presentation entitled (المنومات بين الأرق و الادمان), The National Association for Drug Prevention, Princess Noura Bint Abdulrahman University

December 2008:                                  KSU The week of drug poisoning prevention, National Medication Education Team, Saudi Food and Drug Authority (SFDA)

December 2008:                                  AlNahdah The week of drug poisoning prevention, National Medication Education Team, Saudi Food and Drug Authority (SFDA)

November 26, 2007:                            Interactive presentation and demonstration about "Drug Poisoning Prevention" in an open day activity, Kingdom school’s elementary levels, The week of drug poisoning prevention, National Medication Education Team, Saudi Food and Drug Authority (SFDA)

November 13-14,2007:                        Patients Counseling, Open day activity (السكري عند الأطفال والمراهقين                                                           ), Diabetes World National day, Pharmacy department, king

Khaled University Hospital

September 2007:                                 Lecture ( أدويتك في رمضان) , Organizing team, Prince Salman Social Center,  National Medication Education Team, Saudi  Food and Drug Authority (SFDA)

2006-2007:                                          Preparation of 6 arabic brochures entitled,

( السمنة،الانسولين،السالفونايليوريا،الميتفورمين، الجليتازون, الأكاربوز) National Medication Education Team, Saudi  Food and Drug Authority (SFDA)

2006:                                                   Participate2006-2007 in an Open day public health counseling, (تعرفي على أدويتك), in Prince Salman Social Center, Saudi Clinical Pharmacy Club 

2006-2009:                                          Member of the Education & Public Awareness Committee, Saudi Food and Drug Authority (SFDA)

2005-2008:                                          Member of Establishment Committee, Saud Clinical Pharmacy Club

2005:                                                   Participate in an Open day, (أسبوع الدواء) Osteoporosis prevention corner, Alamal hospital   

2005-present:                                      Editor of Pharmacy Spotlights Newsletter Clinical Pharmacy Department, King Saud University

2000:                                                   Participate in an Open public health day, Diabetes and Cholesterol Corner, "University and Society Week", Clinical Pharmacy Department, Pharmacy College, King Saud University

1999:                                                   Participate and organize an Open public health day, “University and Society Week", Clinical Pharmacy Department, Pharmacy College, King Saud University

 

PROFESSIONAL AND ORGANIZATION MEMBERSHIP:

2010-present:                                      The American Society of Human Gene

2006-2010:                                          National Medication Education Team, Saudi Food and Drug Authority (SFDA)

2005-2010:                                          Saud Clinical Pharmacy Club, Establishment Committee

1997-present:                                      Saudi Pharmaceutical Society

 

HONORS:

Second degree honor, year 1996

AWARDS:

2021, March 25:                                  Third place, Best oral presentation award, paper entitled: “Feasibility, Efficacy and Safety of Escitalopram in Functional Gastrointestinal Disorders: A Prospective Cohort Study”, the 10th College of Pharmacy Research day, KSU, Riyadh, Saudi Arabia

2021, March 25:                                  Fifth place, Best oral presentation award, paper entitled: “The impact of quarantine on sleep quality and psychological distress during the COVID-19 pandemic in Saudi Arabia.”, the 10th College of Pharmacy Research day, KSU, Riyadh, Saudi Arabia

2019, April 11:                                    First place, Best oral presentation award, paper entitled: “Whole Exome Sequencing Identifies Novel Gene Associated with Hereditary Spastic Paraplegias Among Saudi Patients”, at the 9th College of Pharmacy Research day, KSU, Riyadh, Saudi Arabia

2019, April 11:                                    First place (tied), Best oral presentation award, paper entitled: “The Role of DIO1, DIO2 and TSHβ Polymorphisms in Differentiated Thyroid Cancer and Patient Response to Therapy in the Saudi Population: A Pharmacogenetic Study”, at the 9th College of Pharmacy Research day, KSU, Riyadh, Saudi Arabia

2019, April 11:                                    Twelfth place, Best student poster presentation award ( pharmaceutical sciences), paper entitled: “ Gene Therapy Knowledge and Attitude among Healthcare Professionals: A Cross-Sectional Study”, at the 9th College of Pharmacy Research day, KSU, Riyadh, Saudi Arabia

2019, March 6,7:                                 First award, Oral presentation competition, paper entitled: “Whole Exome Sequencing Identifies Novel Gene Associated with Hereditary Spastic Paraplegias Among Saudi Patients”, at the 6th pharmacy research symposium, College of pharmacy, Qassim University), Qassim, Saudi Arabia

2019, February 26-28:                         First place, Best student poster presentation award, paper entitled: “Whole Exome Sequencing Identifies Novel Gene Associated with Hereditary Spastic Paraplegias Among Saudi Patients”, at the at the DUPHAT, Dubai, UAE

2019, January 23-24:                          First place, Best student poster presentation award (pharmaceutical sciences), paper entitled: “Whole Exome Sequencing Identifies Novel Gene Associated with Hereditary Spastic Paraplegias Among Saudi Patients”, at the Saudi International Pharmaceutical Science Meeting and Workshops (SIPHA), Jeddah, Saudi Arabia

2018, April 25-26:                               Third place, Best student oral presentation award, paper entitled: “Genetic Analysis of Long QT Syndrome in Saudi Arabia: Identification of Causative Mutation and the Role of KCNQ1 and AKAP9”, at the 8th College of Pharmacy Research day, KSU, Riyadh, Saudi Arabia

2018, April 25-26:                               First place, Best student oral presentation award paper entitled: “Identification of a Novel ETFB Missense Mutation in Saudi Adult with Glutaric Aciduria Type II”, at the 8th College of Pharmacy Research day, KSU, Riyadh, Saudi Arabia

2018, April 25-26:                               Best postgraduate poster presentation award paper entitled: “Autosomal Recessive Cerebellar Ataxia Caused by a Novel Cys89Ser Mutation in a Saudi Family”, at the 8th College of Pharmacy Research day, KSU, Riyadh, Saudi Arabia

2018, February 27-March 1:               Fourth place, Best student oral presentation award, paper entitled: “The Role of KCNQ1 and AKAP9 Variants as Genetic Modifiers of Congenital Long-QT Syndrome Type 1”, at the DUPHAT, Dubai, UAE

2018, February 17-19:                         First place, award winning in the abstract student poster presentation entitled: “A Novel ETFB Mutation in Saudi Adult with Glutaric Aciduria Type II: A Case Report”, at the Saudi International Pharmaceutical Science Meeting and Workshops (SIPHA), Riyadh, Saudi Arabia

2017, November 14:                            First place, award winning in the abstract three minutes’ oral presentation entitled: “Knowledge and Willingness of Physicians about Deprescribing Among Older Saudi Patients: A Qualitative Study”, at the 3rd Scientific Meeting for Medication Safety: Strategies to promote a culture of safety via inter-professional collaboration, Medication Safety Chair, KSU, Riyadh, Saudi Arabia

2017, April 20:                                    First place, award winning in the abstract oral presentation entitled: “Identification of Novel Missense Mutation in a Saudi Family with Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency”, at the 3rd PharmD Research day, Clinical Pharmacy department, KSU, Riyadh, Saudi Arabia

2017, April 20:                                    Second place, award winning in the abstract oral presentation entitled: “Two Novel Mutations in Glucosidase Alpha Acid Gene Causing Pompe Disease in Three Saudi Families” at the 3rd PharmD Research day, Clinical Pharmacy department, KSU, Riyadh, Saudi Arabia

2017, April 20:                                    Third place, award winning in the abstract oral presentation entitled: “The Role of CDKN2B Gene in Coronary Artery Disease and Myocardial Infarction and Their Risk Traits in the Ethnic Saudi Arabs: A Validation Study”, at the 3rd PharmD Research day, Clinical Pharmacy department, KSU, Riyadh, Saudi Arabia

2017, April 11:                                    First place, award winning in the abstract poster presentation entitled paper entitled: “Knowledge and Willingness of Physicians about Deprescribing Among Older Saudi Patients: A Qualitative Study”, at the Medication Safety Chair Day, KSU, Riyadh, Saudi Arabia

2017, March 7-9:                                 Best innovation award, paper entitled: “Identification of Novel Missense Mutation in a Saudi Family with Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency”, at the DUPHAT, Dubai, UAE

2017, March 7-9:                                 Best professional abstract oral presentation award, paper entitled: “Knowledge and Willingness of Physicians about Deprescribing Among Older Saudi Patients: A Qualitative Study”, at the DUPHAT, Dubai, UAE

2017, March 7-9:                                 Best student abstract oral presentation award, paper entitled: “The Role of CDKN2B Gene in Coronary Artery Disease and Myocardial Infarction and Their Risk Traits in the Ethnic Saudi Arabs: A Validation Study”, at the DUPHAT, Dubai, UAE

2016, April 13:                                    First place, award winning in the abstract oral presentation entitled: “A Study of the Role of PAX8 Gene Polymorphism in the Manifestation and Drug Therapy of Differentiated Thyroid Cancer”, at the 2nd PharmD Internship Research day, Clinical Pharmacy department, KSU, Riyadh, Saudi Arabia

2016, April 13:                                    Second place, award winning in the abstract oral presentation entitled: “Mutation Identification in DOLK Gene in Saudi Family with Dilated Cardiomyopathy “at the 2nd PharmD Internship Research day, Clinical Pharmacy department, KSU, Riyadh, Saudi Arabia

2016, April 13:                                    Second place, award winning in the abstract oral presentation entitled: “Clinical and Molecular Characterization of Patients with Long QT Syndrome in Saudi Patients”, at the 2nd PharmD Internship Research day, Clinical Pharmacy department, KSU, Riyadh, Saudi Arabia

2015, May14:                                      First place, award winning in the abstract poster presentation entitled: “The Effect of Omega-3 Fatty Acid and Aloe Vera Oil Combination on Improving Skin Hardness and Thickness: A Randomized-Double Blind Controlled Study “, at the Pharmacy Research day, College of pharmacy, KSU, Riyadh, Saudi Arabia

2015, May21st:                                    First place, award winning in the abstract oral presentation entitled: “Genetic Analysis of Barter’s and Giltelman’s Syndromes in Saudi Patients”, at the 1st PharmD Internship Research day, Clinical Pharmacy department, KSU, Riyadh, Saudi Arabia

2012, January:                                    First Place, award winning in the abstract oral presentation entitled: “Genetic determinants of L-thyroxine dose requirement in athyrotic patients with differentiated thyroid cancer and their potential role in its etiology “held on 18 January 2012 at the 5th Annual Residents’ Research Day, KFSH&RC, Riyadh, Saudi Arabia http://news.ksu.edu.sa/news/36183?utm_source=twitterfeed&utm_medium=twi…

2008, June:                                         The Best faculty member at School of pharmacy Award which granted from pharmacy graduates class 1428-1429(2007-2008) second semester, at the pharmacy college ceremony on Sunday, 18/06/1429 H (June 2008)

 

PROFESSIONAL ACTIVITIES:

2020 October-February:                     Contribute in (Oral Biology and Genetics) lectures- The Saudi Board for Oral Medicine and Pathology

2020, 26-30 August:                            paper entitled “Utilization patterns of multiple sclerosis medications in Saudi Arabia: A cross-sectional retrospective study”, the ISPE’s 36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) Berlin, Germany

2019, 21-23 March:                             paper entitled “A study of the role of DIO1, DIO2 and TSHβ polymorphism in differentiated thyroid cancer and drug response to therapy in the Saudi population: a case-control study”, the NACC Orlando, USA

2019, 15-18 June:                                paper entitled “Novel glycine receptor variants identified in startle disease patients” the European Conference of Human Genetics in Gothenburg, Sweden

2019, March 6-7:                                 paper entitled “Whole Exome Sequencing Identifies Novel Gene Associated with Hereditary Spastic Paraplegias Among Saudi Patients” poster presentation, 7th Kuwait International Pharmacy Conference (KIPC) 2019

2019, March 6-7:                                 paper entitled “Whole Exome Sequencing Identifies Novel Gene Associated with Hereditary Spastic Paraplegias Among Saudi Patients” poster presentation, The 6th pharmacy research symposium, College of pharmacy, Qassim University, Qassim, Saudi Arabia

2019, February 26-28:                         paper entitled “The Role of DIO1, DIO2 and TSHβ Polymorphism in Differentiated Thyroid Cancer and Drug Response to Therapy in the Saudi Population: A Pharmacogenetic Study” poster presentation, DUPHAT, Dubai, UAE

2019, February 26-28:                         paper entitled “Whole Exome Sequencing Identifies Novel Gene Associated with Hereditary Spastic Paraplegias Among Saudi Patients” oral presentation, DUPHAT, Dubai, UAE

2019, January 23-24:                           paper entitled “Whole Exome Sequencing Identifies Novel Gene Associated with Hereditary Spastic Paraplegias Among Saudi Patients” poster presentation, SIPHA, Jeddah, KSA

2018, April 25-26:                               Paper entitled: “Genetic Analysis of Long QT Syndrome in Saudi Arabia: Identification of Causative Mutation and the Role of KCNQ1 and AKAP9”, at the 8th College of Pharmacy Research day, KSU, Riyadh, Saudi Arabia

2018, April 25-26:                               Paper entitled: “Identification of a Novel ETFB Missense Mutation in Saudi Adult with Glutaric Aciduria Type II”, at the 8th College of Pharmacy Research day, KSU, Riyadh, Saudi Arabia

2018, April 25-26:                               Paper entitled: “Autosomal Recessive Cerebellar Ataxia Caused by a Novel Cys89Ser Mutation in a Saudi Family”, at the 8th College of Pharmacy Research day, KSU, Riyadh, Saudi Arabia

2018, February 27-March 1:               paper entitled “A Novel ETFB Mutation in Saudi Adult with Glutaric Aciduria Type II: A Case Report” oral presentation, DUPHAT, Dubai, UAE

2018, February 27-March 1:               paper entitled “The Role of KCNQ1 and AKAP9 as Genetic Modifier of Congenital Long-QT Syndrome” oral presentation, DUPHAT, Dubai, UAE

2018, February 19-20:                         paper entitled “A Novel ETFB Mutation in Saudi Adult with Glutaric Aciduria Type II: A Case Report” poster presentation, SIPHA, Riyadh, KSA

2018, February 19-20:                         paper entitled “The Role of KCNQ1 and AKAP9 as Genetic Modifier of Congenital Long-QT Syndrome” poster presentation, SIPHA, Riyadh, KSA

2017, March 7-9:                                 paper entitled “Knowledge and Willingness of Physicians about Deprescribing Among Older Saudi Patients: A Qualitative Study” oral presentation, DUPHAT, Dubai, UAE

2017, March 7-9:                                 paper entitled “Patients’ knowledge of and willingness to Vaccination through Community Pharmacy among adults in Saudi Arabia” oral presentation, DUPHAT, Dubai, UAE

2017, March 7-9:                                 paper entitled “Genetic Analysis of Pompe Disease in Saudi Patients” presentation, DUPHAT, Dubai, UAE

2017, March 7-9:                                 paper entitled “The Role of CDKN2B Gene in Coronary Artery Disease and Myocardial Infarction in Ethnic Saudi Arabs: A Validation Study” oral presentation, DUPHAT, Dubai, UAE

2017, March 7-9:                                 paper entitled “Identification of Novel Missense Mutation in Saudi Family with Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency” oral presentation, DUPHAT, Dubai, UAE

2016, November:                                 participate in preparation of Pharmacy-Based Immunization Delivery booklet.

2016, 21-24 May:                                paper entitled “‘A genome-wide association study for hypertriglyceridemia in ethnic Saudi Arabs” presented in the European Conference of Human Genetics in Barcelona, Spain

2015, 6-9June:                                     paper entitled “The TSH-beta gene confers a risk for differentiated thyroid cancer in the Saudi population “was presented at the European Conference of Human Genetics 2015 in Glasgow, Scotland

2015, February 25th:                            Meet the Accreditation Council for Pharmacy Education (ACPE) on his regular visit to the college of pharmacy, KSU

2015, February 7th:                             Judge, The Sixth Scientific Meeting. King Saud University, Riyadh, Saudi Arabia

February 1-2,2015:                             Attend workshop entitled “School of Pharmacy faculty members supporting program”. School of Pharmacy.  KSU. Riyadh. Saudi Arabia.

December 3, 2014:                              Supervise and arrange for “Commit to be fit” campaign, College of Pharmacy, King Saud University, Saudi Arabia

October-December,2014:                    Supervise and arrange for weekly seminars presented by Master students as part of 591PHCL course in KKUH as part of the Pharmacy activity to all staff. KKUH, Saudi Arabia

October-December,2014:                    Supervise and arrange for weekly seminars presented by Master students as part of 590PHCL course in College of Pharmacy as part of the course activity. College of Pharmacy, KSU, Saudi Arabia

February 1-2,2014:                             Attend workshop entitled “Prince Naif Research center workshop”. Ritz Hotel. Riyadh. Saudi Arabia.

January 18,2012:                                 Oral presentation entitled “Genetic determinants of L-thyroxine dose requirement in athyrotic patients with differentiated thyroid cancer and their potential role in its etiology “was presented at the 5th Annual Residents’ Research Day, KFSH&RC, Riyadh, Saudi Arabia

November 23, 2011:                            Oral presentation entitled “The Role of Gene Polymorphism in the Etiology of Differentiated Thyroid Cancer and L-thyroxine Dose Requirement in Athyrotic Patients” was presented at KKUH, Riyadh, Saudi Arabia

October 11-15, 2011:                           paper entitled “Thrombospondin 4 gene harbours a common susceptibility locus for atherosclerosis and its risk traits “was presented at the 12th International Congress of Human Genetics/American Society of Human Genetics 61st Annual Meeting in Montreal, Canada

July7, 2011:                                        presentation of transfer MPhil to PhD entitled “The role of gene polymorphism in the etiology of differentiated thyroid cancer and L-thyroxin dose requirement in athyrotic patients”. PHARMACY AND BIOMOLECULAR SCIENCES, University of Brighton, United Kingdom.

June27-30,2011:                                  paper entitled “Genetic determinants of L-thyroxine dose requirement in athyrotic patients with differentiated thyroid cancer and their potential role in its etiology “was presented in 4TH INTERNATIONAL CONGRESS OF MOLECULAR MEDICINE which was held in Istanbul, Turkey.

April 9-13,2011:                                  Paper entitled “The PON1 is a susceptibility gene for acquiring metabolic Syndrome” was presented in the Experimental Biology meeting which was held in Washington,DC.

November 2-6, 2010:                           Paper entitled “The rs10934857T>C of the GATA2 gene is a susceptibility variant for myocardial infarction”, was presented in the American Society of Human Gene Annual Meeting (ASHG) 2010 which was held in Washington, DC.

July 19,2010:                                       paper entitled “Genetic determinants of L-thyroxine dose requirement in athyrotic patients with differentiated thyroid cancer and their potential role in its etiology” was presented on the Postgraduate Annual Report Presentation day, University of Brighton.

April 24-28, 2010:                               Paper entitled “The rs2228671C>T of the LDLR gene confers risk for low HDL and early onset of coronary artery disease”, was presented in the Experimental Biology meeting which was held at the Anaheim, California

April 24-28, 2010:                               Paper entitled “The Ser377Gly of the GATA4 gene is a susceptibility variant for hypertension”, was presented in the Experimental Biology meeting which was held at the Anaheim, California

July 14th 2009:                                     presentation entitled” The Role of Gene Polymorphisms in Thyroid Hormone Dose Requirement in Thyroid Cancer “, The Postgraduate Annual Report Presentation day, PHARMACY AND BIOMOLECULAR SCIENCES, University of Brighton, United Kingdom

July 12-15 ,2009:                                 Paper entitled “Identification of haplotypes in the LDLR gene conferring risk for premature CAD and heterozygous familial hyperlipidemia”, was presented in the 9th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT-2009) which was held at the Edinburgh, Scotland

May 5-10,2009:                                   Presentation entitled (المنومات بين الأرق و الادمان), The National Association for Drug Prevention, Princess Noura Bint Abdulrahman University

December 2008:                                  KSU The week of drug poisoning prevention, National Medication Education Team, Saudi Food and Drug Authority (SFDA)

December 2008:                                  Alnahdah The week of drug poisoning prevention, National Medication Education Team, Saudi Food and Drug Authority (SFDA)

November 26, 2007:                            Interactive presentation and demonstration about "Drug Poisoning Prevention" in an open day activity, Kingdom school’s elementary levels, The week of drug poisoning prevention, National Medication Education Team, Saudi Food and Drug Authority (SFDA)

November 13-14,2007:                        Patients Counseling, Open day activity (السكري عند الأطفال والمراهقين                                                           ), Diabetes World National day, Pharmacy department, king

Khaled University Hospital

September 2007:                                 Lecture (أدويتك في رمضان), Organizing team, Prince Salman Social Center, National Medication Education Team, Saudi Food and Drug Authority (SFDA)

2006-2007:                                          Preparation of 6 Arabic brochures entitled, (السمنة،الانسولين،السالفونايليوريا،الميتفورمين، الجليتازون, الأكاربوز) National Medication Education Team, Saudi Food and Drug Authority (SFDA)

2006:                                                   Participate2006-2007 in an Open day public health counseling, (تعرفي على أدويتك), in Prince Salman Social Center, Saudi Clinical Pharmacy Club  

2005:                                                   Participate in an Open day, (أسبوع الدواء) Osteoporosis prevention corner, Alamal hospital                     

2005-present:                                      Editor of Pharmacy Spotlights Newsletter Clinical Pharmacy Department, King Saud University

2000:                                                   Participate in an Open public health day, Diabetes and Cholesterol Corner, "University and Society Week", Clinical Pharmacy Department, Pharmacy College, King Saud University

1999:                                                   Participate and organize an Open public health day, "University and Society Week", Clinical Pharmacy Department, Pharmacy College, King Saud University

 

BIBLIOGRAPHY AND RESEARCH

 

A. SCIENTIFIC ARTICLES & PAPERS IN PEER REVIEW JOURNALS:

1. Aboheimed GI, AlRasheed MM, Almudimeegh S, Peña-Guerra KA, Cardona- Londoño KJ, Salih MA, Seidahmed MZ, Al-Mohanna F, Colak D, Harvey K, Arold ST, Kaya N, Ruiz
   AJ, Clinical, genetic, and functional characterization of the glycine receptor β-subunit A455P variant
   in a family affected by hyperekplexia syndrome, Journal of Biological Chemistry (2022), doi: https:// doi.org/10.1016/j.jbc.2022.102018.
2. Omar A. Alhaj, Noor J. Altoo, Ahmad F. Alenezi, Abdulrahman I. Janahi, Maha M. AlRasheed, Bernard Faye. Camel milk composition by breed, season, publication year, and country: A global systematic review, meta-analysis, and meta-regression. Compr Rev Food Sci Food Saf. 2022;1–40
3. Mezna A. AlMarzooqi, Omar Alhaj, Maha M. AlRasheed, Mai Helmy, Khaled Trabelsi, Ahmed Ebrahim, Suhaib Hattab, Haitham A. Jahrami, Helmi Ben Saad. Symptoms of Nomophobia, Psychological Aspects, Insomnia and Physical Activity: A Cross‐Sectional Study of ESports Players in Saudi Arabia. Healthcare 2022, 10, 257.
4. Marcello Scala et al. Clinico-radiological features, molecular spectrum, and identification of new prognostic factors in early infantile epileptic encephalopathy due to inosine triphosphate pyrophosphatase (ITPase) deficiency. Human Mutation. 2022 Mar;43(3):403-419. doi: 10.1002/humu.24326.
5. Haitham A. Jahrami, Omar A. Alhaj, Ali M. Humood, Ahmad F. Alenezi, Feten Fekih-Romdhane, Maha M. AlRasheed, Zahra Q. Saif, Nicola Luigi Bragazzi, Seithikurippu R. Pandi-Perumal, Ahmed S. BaHammam, Michael V. Vitiello. Sleep disturbances during the COVID-19 pandemic: A systematic review, meta-analysis, and meta-regression. Sleep Medicine Reviews 62 (2022) 101591.
6. Maha M. AlRasheed, Sinaa Al-Aqeel, Afnan M. Alkadir, Khloud I. Bin Shuqiran, Fowad Khurshid, Noura M. AlRasheed, Roua M. Al-kufeidy, Omar A. Alhaj, Haitham A. Jahrami, Ahmad S. BaHammam. The prevalence of psychological distress and its relationship to sleep quality in Saudi Arabia's general population during the COVID-19 pandemic. Frontiers in Psychiatry. February 2022. DOI: 10.3389/fpsyt.2021.809040
7. Ayah Talal Zaidalkilani, Omar A. AlHaj , Mohamed Fekry Serag El-din, Feten Fekih-Romdhane, Maha M AlRasheed, Haitham A. Jahrami, Nicola Luigi Bragazzi. Arab Women Adherence to the Mediterranean Diet and Insomnia. Medicina 2022, 58(1), 17; https://doi.org/10.3390/medicina58010017
8. Hesham AlDhalaan, Albandary AlBakheet, Sarah AlRuways, Nouf
   AlMutairi, Maha AlNakiyah, Reema Alghofaili, Kelly Y. Cordona Londono, KHALID
   OMAR ALAHMADI, Hanan AlQudairy, Maha M AlRasheed, Dilek Colak, Stefan T
   Arold, Namik Kaya. Novel GEMIN4 variant in a consanguineous family leading to
   neurodevelopmental impairment with severe microcephaly, spastic quadriplegia,
   epilepsy, cataracts, and renal abnormalities. Genes 2022, 13, 92. https://doi.org/10.3390/genes13010092
9. Maha M. AlRasheed, Hatoon AlAli, , Abdulrahman F. Alsuwaid, Suhail Khalaf, Sondus I. Ata, Nasser F.BinDhim, DanaBakheet, Fowad Khurshid, Tariq M. Alhawassi. Gene Therapy Knowledge and Attitude Among Healthcare Professionals: A Cross-Sectional Study. Frontiers in Public Health. November 2021 | Volume 9 | Article 773175. doi: 10.3389/fpubh.2021.773175
10. Hatem Abuelizz, Maha M. AlRasheed, Ali Alhoshani, Tariq M.
    Alhawassi.  Genetic Insights into the Susceptibility and Prevention to Middle East
    Respiratory Syndrome Coronavirus Infection: A Genetic Analysis in the Saudi
    Population. Vaccines 2021, 9(10), 1193; https://doi.org/10.3390/vaccines9101193
11. Haitham Jahrami, Mona Rashed; Nicola Luigi Bragazzi; Zahra Saif; Maha AlRasheed; Omar Alhaj; Ahmed S BaHammam; Michael V. Vitiello. Nomophobia is associated with insomnia but not with age, sex, BMI, or mobile phone screen size in young adults. Nature and Science of Sleep 2021:13 1–11
12. Mohammed A. Al-Muhaizea, Hanouf Aldeeb, Rawan Almass, Felwa BinHumaid, Laila AlQuait, Musaad Abukhalid, Hesham AlDhalaan, Maysoon Alsagob, Hadeel Jaber, Mazhor Aldosary, Hadeel Alkofide, Maha M. AlRasheed, Dilek Colak, Namik Kaya. Genetics of Ataxia Telangiectasia in a Highly Consanguineous Population. The Annals of Human Genetics. 28 September 2021. https://doi.org/10.1111/ahg.12445. 
13. Maha M. AlRasheed, Amani H. AlShahrani, Sara A. AlMuhaini, Hadeel A. AlKofide, Tariq M. Alhawassi, Ahmed F. Aldemerdash, Omar A. Alhaj, Nicola L. Bragazzi, Haitham A. Jahrami. Knowledge, Attitude and Practice towards COVID-19 among Pharmacists: A Cross-Sectional Study. Risk Management and Healthcare Policy 2021:14 3079–3090.
14. Fadilah S. Aleanizy, Fulwah Y. Alqahtani, Marzouqah S. Alanazi,
    Rania A.E.H. Mohamed, Bahauddeen M. Alrfaei, Mana M. Alshehri, Hajar AlQahtani, Ghalia Shamlan, Nassr Al-Mafleh, Maha M. Alrasheed, Ahmed Alrashed.   Clinical characteristics and risk factors of patients with severe COVID-19 in Riyadh, Saudi Arabia: A retrospective study. Journal of Infection and Public Health 14 (2021) 1133–1138
15. Maha M. AlRasheed, Afnan M. Alkadir, Khloud I. Bin Shuqiran, Sinaa Al-Aqeel, Haitham A. Jahrami, Ahmad S BaHammam. The impact of quarantine on sleep quality and psychological distress during the COVID-19 pandemic. Nature and Science of Sleep 2021:13 1037–1048
16. Omar A. Alhaj, Hiba F. Al-Sayyed, Maha M. AlRasheed, Haitham Jahrami. Appraisal Survey of the Knowledge, Attitudes, and Behaviors of Jordanian Society toward Diet and Nutrition during COVID-19 era. Journal of Public Health Research 2021; 10:2381. doi: 10.4081/jphr.2021.2381.
17. Maha M. AlRasheed, Abdullah M. Alsugair, Hala F.Almarzouqi, Gadah K. Alonazi, Fadilah .S. Aleanizy, Fulwah Y. Alqahtani ,Gamal A. Shazly, Fowad Khurshid. Assessment of Knowledge, Attitude and Practice of Security and Safety Workers towards COVID-19 Pandemic: A Cross-Sectional Study. Front. Public Health.2021; 9: 631717| https://doi.org/10.3389/fpubh.2021.631717
18. Lamya H. Al-Wahaibi , Muneera S. M. Al-Saleem, Osama A. A. Ahmed , Usama A.Fahmy , Nabil A. Alhakamy , Basma Eid , Ashraf Abdel-Naim , Wael M. Abdel-Mageed , Maha AlRasheed , Gamal A. Shazly. Factorial design of fluvastatin-HIV-1 TAT electrostatic conjugation for enhanced pro-apoptotic activity in HepG2 cells. International Journal of Molecular Sciences. Int. J. Mol. Sci. 2020, 21(11), 4138; https://doi.org/10.3390/ijms21114138
19. Mohammad A. Al-Muhaizea, Laila AlQuait, Afnan AlRasheed, Shoug AlHarbi , Anoud Abdulmalik Albader, Rawan AlMass, Albandary Albakheet, Abdullah Alhumaidan, Maha M. AlRasheed, Dilek Colak, Namik Kaya. Pyrostigmine therapy in a patient with VAMP1-related congenital myasthenic syndrome. Neuromuscular Disorders(NMD). 2020, 12(58), 1-5;  https://doi.org/10.1016/j.nmd.2020.04.007
20. Salha Jokhab; Farhad Kamali; Maha Al-Rasheed; Dana Makheet; Peter Avery; AbdulKareem Al-Momen. Assessment of the effect of VKORC1 and CYP2C9 polymorphisms on warfarin dose requirements in Saudi patients: Interim results of a large cross-sectional study. British Journal of Clinical Pharmacology (BJCP).https://doi.org/10.1111/bcp.14266
21. Maha M. AlRasheed, Lina F. Hammad, Abeer F. Altaweel, Alaa A. Assiri, Albatool A. Bin Ajlan, Rawan A. Almugbel, Shaikha Y. Aldukhail, Norah O. Abanmy, Gamal A. Shazly. “Improving Skin Hardness and Thickness using a combination of Omega-3 Fatty Acid and Aloe Vera Oil: Pilot study.  J. Adv. Biomed. & Pharm. Sci. 3 (2020) 60-64
22. Ashwaq Mohammed Alanazi, Rawan Alshalhoub, Maha Meshal Alrasheed, Nora Abanamy, Dana Bakheet, Nduna Dzimir. The Rs1388378 Polymorphism in the Human DIO2 Gene is Associated with Decreased L-Thyroxine Dose Requirement in Thyroidectomized Patients. Journal of the National Comprehensive Cancer Network 2019;17(3.5):CGE19-062
23. Maha M. AlRasheed, Ashwaq AlAnzi, Rawan AlShalhoub , Norah O. Abanmy, Dana Bakheet.  “A study of the role of DIO1 and DIO2 polymorphism in thyroid cancer and drug response to therapy in the Saudi population”. SPJ 2019; 27(6):841-45.
24. Fulwah Y. Alqahtani, Fadilah Sfouq Aleanizy, Rania Ali El Hadi Mohamed, Marzouqah Alanazi, Maha Alrasheed, Nourah Abanmy and Tariq Alhawwasi. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus: A retrospective study. Epidemiology & Infection. 2019;147:1-5
25. Maha M. AlRasheed, MennatAllah M. Hefnawy, Nourhan N. Elsherif, Tariq M. Alhawassi, Norah O. Abanmy, Nora M. AlRasheed, Fulwah Y. Alqahtani, Fadilah S. Aleanizy, Olayan M Al-Boudari, Nduna Dzimiri.  “The role of CDKN2B in cardiovascular risk in ethnic Saudi Arabs: A validation study”. Gene 2018;673:206-210.
26. Maha Meshal AlRasheed, “Evaluation of the role of CDKN2B gene in type 2 diabetes mellitus and hypertension in ethnic Saudi Arabs”. SPJ2018; 26(8):1199-1203.
27. Maha M. Al-Rasheed , Tariq Alhawassi, Alanoud Alanazi, Nouf Aloudah, Fowad Khurshid, Mohammed Alsultan. “Knowledge and Willingness of Physicians about Deprescribing Among Older Saudi Patients: A Qualitative Study”. Clinical Interventions in Aging 2018.
28. Bander Balkhi, Hisham Aljadhey, Mansour A. Mahmoud, Maha Alrasheed, Lisa G Pont, Alemayehu B Mekonnen, Tariq M Alhawassi. Readiness and Willingness to Provide Immunization Services: A Survey of Community Pharmacists in Saudi Arabia. Safety in Health (2018) 4:1.
29. Sara Alqahtani, Tariq Alhawassi, Bander Balkhi, Maha Alrasheed, Mansour Mahmoud, Hisham Aljadhey. Public Willingness to Receive Vaccination in Community Pharmacies in Saudi Arabia. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 2017; 26(Suppl. 2): 637–674.
30. Maha M. Al-Rasheed, Nduna Dzimiri. “The Role of CDKN2B Gene in Coronary Artery Disease and Myocardial Infarction in Ethnic Saudi Arabs: A Validation Study”. The European Conference of Human Genetics in Denmark, Copenhagen,27-30 May,2017.
31. Alrasheed MM, Ali Alzahrani, Gard P, Dzimiri N. The potential role of the PAX8 gene polymorphism in the development of differentiated thyroid cancer. May 2016. Submitted
32. Maha M. Al-Rasheed, Nduna Dzimiri. “A genome-wide association study for hypertriglyceridemia in ethnic Saudi Arabs”. The European Conference of Human Genetics in Barcelona, Spain,21-24 May,2016
33. Alrasheed MM, Ali Alzahrani, Gard P, Dzimiri N. The potential role of the sodium symporter gene polymorphism in the development of differentiated thyroid cancer.  Gene. 2015 Jul 6. 
34. Maha M. Al-Rasheed, Ali S. Alzahrani, Angela Macadam, Andrew Overall, Paul Gard, Nduna Dzimiri. The TSH-beta gene confers a risk for differentiated thyroid cancer in the Saudi population. The European Society of Human Genetics 2015, Glasgow, Scotland, 2015, 6-9June,2015
35. Maha M. Al-Rasheed, Ali S. Alzahrani, Angela Macadam, Andrew Overall, Paul Gard, Nduna Dzimiri.  The potential role of the sodium symporter gene polymorphism in the development of differentiated thyroid cancer.  World Congress of Pharmacology, Cape Town, South Africa, July 13-18, 2014.
36. Alzahrani A, AlShaikh O, Tuli M, Al-Sugair A, Alamawi R, and Al-Rasheed M. Diagnostic value of recombinant human thyrotropin-stimulated iodine-123 whole-body scintigraphy in the follow-up of patients with differentiated thyroid cancer. Clin Nucl Med 2012;37(3): 229–234
37. M. M. Alrasheed, M. G. Vigilla, D. Gueco, P. Muiya, S. Elhawari, M. Al-Najai, E. Andres, B. F. Meyer, M. Alshahid, N. Dzimiri. Thrombospondin 4 gene harbours a common susceptibility locus for atherosclerosis and its risk traits. The 12th International Congress of Human Genetics/American Society of Human Genetics 61st Annual Meeting, October 11-15, 2011, Montreal, Canada
38. Maha M. Al-Rasheed, Angela Macadam, Andrew Overall, Ali Alzahrani, Nduna Dzimiri and Paul R. Gard. Genetic determinants of L-thyroxine dose requirement in athyrotic patients with differentiated thyroid cancer and their potential role in its etiology.  The 4TH INTERNATIONAL CONGRESS OF MOLECULAR MEDICINE, June27-30,2011. Istanbul, Turkey.
39. Maha Al-Rasheed, Mohammed Al-Najaia, Mary Grace B. Vigillaa, Paul Muiyaa, and Nduna Dzimiri. The PON1 is a susceptibility gene for acquiring metabolic Syndrome. The Experimental Biology meeting which was held in April 9-13, 2011, Washington, DC.
40. Maha Al-Rasheed, and Nduna Dzimiri. The rs10934857T>C of the GATA2 gene is a susceptibility variant for myocardial infarction”. The American Society of Human Gene Annual Meeting (ASHG) 2010. November 2-6, 2010, Washington, DC.
41. Maha M Alrasheed, Paul Muiya, Salma Wakil, Mohammed Al-Najai, Editha Andres, Nejat Mazher and Nduna Dzimiri. The rs2228671C>T of the LDLR gene confers risk for low HDL and early onset of coronary artery disease. FASEB J, Supplement lb134, Experimental Biology 2010,  Anaheim, California April 24-28, 2010
42. Maha M Alrasheed, Paul Muiya, Daisy Gueco, Editha Andres, Maie Alshahid and Nduna Dzimiri. The Ser377Gly of the GATA4 gene is a susceptibility variant for hypertension. FASEB J, Supplement lb135, Experimental Biology 2010, Anaheim, California April 24-28, 2010
43. Muiya P, Al-Najai M, Dzimiri N and Alrasheed M.  Identification of haplotypes in the LDLR gene conferring risk for premature CAD and heterozygous familial hyperlipidemia. Basic and Clinical Pharmacology and Therapeutics 2009, 105, Suppl 1, MP97, 68, 9th Congress of the European Association for Clinical Pharmacology and Therapeutics, Edinburgh, UK, 12-15th July, 2009
44. Alkharfy KM, Alrasheed M, Alotaibi B, Almitwazy A, Almutairi M.   Effect of aminoglycoside dosing on magnesium levels in hospitalized patients. Int J Antimicrob Agents. 2007 Aug;30(2):189-90.
45. Maha M. Al-Rasheed and Hisham S. Abou-Auda. Donepezil: A new cholinesterase inhibitor for the treatment of Alzheimer’s disease. Saudi Pharm J 1998; 6(1):99-101

 

B. SUBMITTED PAPERS

 

1. Maha M. AlRasheed ; Feten Fekih-Romdhane; Haitham Jahrami; Pires, Gabriel; Zahra Saif; Ahmad Elenezi; Ali Humood; Wen Chen; Haijiang Dai; Nicola Bragazzi; Seithikurippu Pandi-Perumal; Ahmed Bahammam; Michael Vitiello. The prevalence and severity of insomnia symptoms during COVID-19: a global systematic review and individual participant data meta-analysis. Sleep. Submitted April 2022.
2. Hessah Almutairi, Abeer Alsubaiei, Sara Abduljawad, Amna Alshatti, Feten Fekih-Romdhane, Huda Rashid, Omar Alhaj, Maha M. AlRasheed, Nicola Bragazzi, Haitham Jahrami .A systematic review, meta-analysis, and meta-regression of the prevalence of emotional burnout and its individual components in medical students. Medical Education. Submitted January 2022.
3. Feten Fekih-Romdhane; Maha M. AlRasheed; Zahra Saif; Nicola Luigi Bragazzi; Omar Alhaj; Seithikurippu R. Pandi-Perumal; Ahmed S. BaHammam; Michael V. Vitiello ; Haitham Jahrami. A social media outage is associated with a surge in nomophobia but not anxiety or insomnia symptoms. Computers in Human Behavior. Submitted November 2021.

 

C. CHAPTERS:

 

1. Chapter 54 Al Garni T, Arafat A, AlRasheed M. Withdrawal studies: Design, measures, classic example, accepted in Translational Cardiology Textbook, Published by ElSevier. Under production.
2. Chapter 55 Al Garni T, Arafat A, AlRasheed M. Factorial design: Design measures, classic example, accepted in Translational Cardiology Textbook, Published by Elsevier. Under production.
3. Ahmed Ebrahim, Mai Helmy, Shahenaz Najjar, Omar Alhaj, Khaled Trabelsi, Maha Alrasheed and Haitham Jahrami. (2022) Researchers’ Motivation and Its Correlates: An Empirical Study Amid COVID-19 Pandemic in Arab Region. In: Hamdan A., Hassanien A.E., Mescon T., Alareeni B. (eds) Technologies, Artificial Intelligence and the Future of Learning Post-COVID-19. Studies in Computational Intelligence, vol 1019. Springer, Cham. https://doi.org/10.1007/978-3-030-93921-2_24.
4. Maha M. Alrasheed & Nduna Dzimiri. Chapter book entitled “Ethnicity and response to drug therapy” in the book: Cholesterol Lowering Therapies and Drugs. InTech - Open Access Publisher, ISBN 978-953-51-4761-9. 2016.

 

D. BOOKS

 

1. Saudi National Formulary (SNF) 4th Edition, 2009-2010, Formulary Reviewer.

 

E. ONGOING RESEARCH ACTIVITY:

Writing a research handbook about research in collaboration with an international author group. The book will include chapters on how to write a manuscript, how to review for journals, how to perform basic statistics and basic epidemiological concepts. 

 

F. SCIENTIFIC ABSTRACTS PRESENTED IN NATIONAL AND INTERNATIONAL SCIENTIFIC MEETINGS

 

1. Feasibility, Efficacy and Safety of Escitalopram in Functional Gastrointestinal Disorders: A Prospective Cohort Study. Hala Almarzougi, Ghada Alenzi, Amani Alshahrani, and Maha AlRasheed. “Presentation” the 10th College of Pharmacy Research day, KSU, March 2021, Riyadh, Saudi Arabia.
2. The impact of quarantine on sleep quality and psychological distress during the COVID-19 pandemic in Saudi Arabia. Maha M. AlRasheed, Afnan M. Alkadir, Khloud I. Bin Shuqiran, Sinaa Al-Aqeel, Haitham A. Jahrami, Ahmad S BaHammam. “Presentation” the 10th College of Pharmacy Research day, KSU, March 2021, Riyadh, Saudi Arabia.
3. Utilization patterns of multiple sclerosis medications in Saudi Arabia: A cross-sectional retrospective study. . Almaha H. Alfakhri, Zakiyah M. Alkherb, Tariq M. Alhawassi, Maha M. AlRasheed. “Poster” the ISPE’s 36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), August 2020, Berlin, Germany
4. A study of the role of DIO1, DIO2 and TSHβ polymorphism in differentiated thyroid cancer and drug response to therapy in the Saudi population: a case-control study. Ashwaq Mohammed Alanazi, Rawan Alshalhoub, Maha Meshal Alrasheed, Nora Abanamy, Dana Bakheet, Nduna Dzimir. “Presentation” the 9th  College of Pharmacy Research day, KSU, April 2019, Riyadh, Saudi Arabia.
5. Whole Exome Sequencing Identifies Novel Gene Associated with Hereditary Spastic Paraplegias Among Saudi Patients. Ashwag al-yousef, Lama Aldawsari, Maha Meshal Alrasheed.  “Presentation” the 9th  College of Pharmacy Research day, KSU, April 2019, Riyadh, Saudi Arabia.
6. A study of the role of DIO1, DIO2 and TSHβ polymorphism in differentiated thyroid cancer and drug response to therapy in the Saudi population: a case-control study. Ashwaq Mohammed Alanazi, Rawan Alshalhoub, Maha Meshal Alrasheed, Nora Abanamy, Dana Bakheet, Nduna Dzimir. “Poster” the NACC , March 2019, Orlando, USA
7. Novel glycine receptor variants identified in startle disease patients. G. Aboheimed, M. ALRasheed, M. Salih, M. AlOwain, M. Alsagob, R. Almass, L. AlQuait, R. Harvey, H. AlDhallaan, O. Dabbagh, A. Ruiz, N. Kaya. “Poster” The European Conference of Human Genetics, June 2019, Gothenburg, Sweden. 
8. Whole Exome Sequencing Identifies Novel Gene Associated with Hereditary Spastic Paraplegias Among Saudi Patients. Ashwag al-yousef, Lama Aldawsari, Maha Meshal Alrasheed. “Poster” the 7th  Kuwait International Pharmacy Conference (KIPC) 2019, March 2019, Kuwait.
9. Whole Exome Sequencing Identifies Novel Gene Associated with Hereditary Spastic Paraplegias Among Saudi Patients. Ashwag al-yousef, Lama Aldawsari, Maha Meshal Alrasheed. “ Poster”, The 6th pharmacy research symposium, College of pharmacy, Qassim University, March 2019, Qassim, Saudi Arabia.
10. The Role of DIO1, DIO2 and TSHβ Polymorphism in Differentiated Thyroid Cancer and Drug Response to Therapy in the Saudi Population: A Pharmacogenetic Study. Ashwaq Mohammed Alanazi, Rawan Alshalhoub, Maha Meshal Alrasheed, Nora Abanamy, Dana Bakheet, Nduna Dzimiri. “Poster”, DUPHAT, February 2019, Dubai, UAE.
11. Whole Exome Sequencing Identifies Novel Gene Associated with Hereditary Spastic Paraplegias Among Saudi Patients. Ashwag al-yousef, Lama Aldawsari, Maha Meshal Alrasheed. “Poster”, DUPHAT, February 2019, Dubai, UAE.
12. Whole Exome Sequencing Identifies Novel Gene Associated with Hereditary Spastic Paraplegias Among Saudi Patients. Ashwag al-yousef, Lama Aldawsari, Maha Meshal Alrasheed. “Poster”, SIPHA, January 2019, Jeddah, KSA.
13. Genetic Analysis of Long QT Syndrome in Saudi Arabia: Identification of Causative Mutation and the Role of KCNQ1 and AKAP9. Hanan Abouzaid, Hissah Almohaini, Maha M. AlRasheed. “Presentation” the 8th  College of Pharmacy Research day, KSU, April 2018, Riyadh, Saudi Arabia.
14. Identification of a Novel ETFB Missense Mutation in Saudi Adult with Glutaric Aciduria Type II. Taghreed Alzahrani, Nora Alkhayyat, Maha M AlRasheed. “Presentation” the 8th  College of Pharmacy Research day, KSU, April 2018, Riyadh, Saudi Arabia.
15. Autosomal Recessive Cerebellar Ataxia Caused by a Novel Cys89Ser Mutation in a Saudi Family. .Maissa Alfuraif, Alisha Alnafisah, Maha AlRasheed. “Presentation” the 8th  College of Pharmacy Research day, KSU, April 2018, Riyadh, Saudi Arabia.
16. A Novel ETFB Mutation in Saudi Adult with Glutaric Aciduria Type II: A Case Report. Taghreed Alzahrani, Nora Alkhayyat, Maha M AlRasheed. “Presentation”, DUPHAT, February 2018, Dubai, UAE.
17. The Role of KCNQ1 and AKAP9 as Genetic Modifier of Congenital Long-QT Syndrome. Hanan Abouzaid, Hissah Almohaini, Maha M. AlRasheed. “Presentation”, DUPHAT, February 2018, Dubai, UAE.
18. The Role of KCNQ1 and AKAP9 as Genetic Modifier of Congenital Long-QT Syndrome. Hanan Abouzaid, Hissah Almohaini, Maha M. AlRasheed. “Poster”, SIPHA, February 2018, Riyadh, KSA.
19. Knowledge and Willingness of Physicians about Deprescribing Among Older Saudi Patients: A Qualitative Study. Maha M. Al-Rasheed , Tariq Alhawassi, Alanoud Alanazi, Nouf Aloudah, Fowad Khurshid, Mohammed Alsultan. “Presentation”, DUPHAT, March 2017, Dubai, UAE.
20. knowledge of and willingness to Vaccination through Community Pharmacy among adults in Saudi Arabia. Sarah Alqahtani, Bander Balkhi, Hisham Aljadhei, Maha M. Al-Rasheed , Tariq Alhawassi “Presentation”, DUPHAT, March 2017, Dubai, UAE.
21. Genetic Analysis of Pompe Disease in Saudi Patients. Latifah Aldukkan, Lama Alharabi, Nourah Alshikh, Maha M. AlRasheed. “Poster”, DUPHAT, March 2017, Dubai, UAE.
22. The Role of CDKN2B Gene in Coronary Artery Disease and Myocardial Infarction in Ethnic Saudi Arabs: A Validation Study. Maha M. AlRasheed, MennatAllah M. Hefnawy, Nourhan N. Elsherif, Tariq M. Alhawassi, Norah O. Abanmy, Nora M. AlRasheed, Fulwah Y. Alqahtani, Fadilah S. Aleanizy, Olayan M Al-Boudari, Nduna Dzimiri. “Presentation”, DUPHAT, March 2017, Dubai, UAE.
23. A genome-wide association study for hypertriglyceridemia in ethnic Saudi Arabs. Maha M. Al-Rasheed, Nduna Dzimiri. “Poster”, The European Conference of Human Genetics , May 2016, Barcelona, Spain.
24. Utilization patterns of multiple sclerosis medications in Saudi Arabia: A cross-sectional retrospective study. Almaha H. Alfakhri, Zakiyah M. Alkherb, Tariq M. Alhawassi, Maha M. AlRasheed. “Poster” the European Conference of Human Genetics, May 2016, Barcelona, Spain.
25. The TSH-beta gene confers a risk for differentiated thyroid cancer in the Saudi population “was presented at the European Conference of Human Genetics. Maha M. Al-Rasheed, Angela Macadam, Andrew Overall, Ali Alzahrani, Nduna Dzimiri and Paul R. Gard. “Poster” the European Conference of Human Genetics, June 2015, Glasgow, Scotland
26. Genetic determinants of L-thyroxine dose requirement in athyrotic patients with differentiated thyroid cancer and their potential role in its etiology. Maha M. Al-Rasheed, Angela Macadam, Andrew Overall, Ali Alzahrani, Nduna Dzimiri and Paul R. Gard. “Presentation” the 5th Annual Residents’ Research Day, KFSH&RC,  January, 2012, Riyadh, Saudi Arabia
27. Thrombospondin 4 gene harbours a common susceptibility locus for atherosclerosis and its risk traits. M. M. Alrasheed, M. G. Vigilla, D. Gueco, P. Muiya, S. Elhawari, M. Al-Najai, E. Andres, B. F. Meyer, M. Alshahid, N. Dzimiri. “Poster” 12th International Congress of Human Genetics/American Society of Human Genetics 61st Annual Meeting, October, 2011, Montreal, Canada.
28. Genetic determinants of L-thyroxine dose requirement in athyrotic patients with differentiated thyroid cancer and their potential role in its etiology. Maha M. Al-Rasheed, Angela Macadam, Andrew Overall, Ali Alzahrani, Nduna Dzimiri and Paul R. Gard.  “Poster” the  4th International Congress Of Molecular Medicine, June, 2011, Istanbul, Turkey.
29. The PON1 is a susceptibility gene for acquiring metabolic Syndrome. Maha Al-Rasheed, Mohammed Al-Najaia, Mary Grace B. Vigillaa, Paul Muiyaa, and Nduna Dzimiri. “Poster” Experimental Biology meeting, April 2011, Washington, DC.
30. The rs10934857T>C of the GATA2 gene is a susceptibility variant for myocardial infarction. Maha Al-Rasheed, and Nduna Dzimiri.  “Poster” the American Society of Human Gene Annual Meeting (ASHG),November 2010, Washington, DC.
31. Genetic determinants of L-thyroxine dose requirement in athyrotic patients with differentiated thyroid cancer and their potential role in its etiology. Maha M. Al-Rasheed, Angela Macadam, Andrew Overall, Ali Alzahrani, Nduna Dzimiri and Paul R. Gard.  “Presentation” the Postgraduate Annual Report Presentation day, July,2010, University of Brighton, Brighton, United Kingdom.
32. The rs2228671C>T of the LDLR gene confers risk for low HDL and early onset of coronary artery disease. Maha M Alrasheed, Paul Muiya, Salma Wakil, Mohammed Al-Najai, Editha Andres, Nejat Mazher and Nduna Dzimiri. “Poster” the Experimental Biology meeting, April, 2010, Anaheim, California
33. The Ser377Gly of the GATA4 gene is a susceptibility variant for hypertension. Maha M Alrasheed, Paul Muiya, Daisy Gueco, Editha Andres, Maie Alshahid and Nduna Dzimiri. “Poster” the Experimental Biology meeting. April,2010, Anaheim, California.
34. The Role of Gene Polymorphisms in Thyroid Hormone Dose Requirement in Thyroid Cancer. Maha M. Al-Rasheed, Angela Macadam, Andrew Overall, Ali Alzahrani, Nduna Dzimiri and Paul R. Gard.   “Presentation” The Postgraduate Annual Report Presentation day, PHARMACY AND BIOMOLECULAR SCIENCES. July, 2009, University of Brighton, Brighton, United Kingdom.
35. Identification of haplotypes in the LDLR gene conferring risk for premature CAD and heterozygous familial hyperlipidemia. Muiya P, Al-Najai M, Dzimiri N and Alrasheed M.  “Poster” the 9th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT-2009). July,2009, Edinburgh, Scotland.

 

G. SCIENTIFIC EDUCATIONAL AND AWARENESS MATERIALS

 

1. The 11th College of Pharmacy Research Day Abstract book (2022). “Author”. The 11th  College of Pharmacy Research day, KSU, May 2022, Riyadh, Saudi Arabia. https://coprd-ksu.com/
2. The 10th College of Pharmacy Research Day Abstract book (2021). “Author”. The 10th  College of Pharmacy Research day, KSU, March 2021, Riyadh, Saudi Arabia. https://coprd-ksu.com/
3. The 9th College of Pharmacy Research Day Abstract book (2019). “Author”. The 9th College of Pharmacy Research day, KSU, April 2019, Riyadh, Saudi Arabia. https://coprd-ksu.com/
4. The 8th College of Pharmacy Research Day Abstract book (2018). “Author”. The 8th College of Pharmacy Research day, KSU, April 2018, Riyadh, Saudi Arabia. https://coprd-ksu.com/
5. The foundation course in clinical medication management-update in therapeutics Book (2018). “ Editor and program director” in collaboration of Deanship of skills and development and Medication Safety Research Chair, KSU. October 2018, Riyadh, Saudi Arabia.
6. Arabic Educational materials (Anti diabetic medication). “Author”.  Organized by National Medication Education Team, Saudi Food and Drug Authority (SFDA). 2006,2007

 

H. WEBSITES ESTABLISHED

 

8. The 11th College of Pharmacy Research Day (idea, supervision, content creator, design), College of Pharmacy, King Saud University (2022) https://coprd-ksu.com/
9. The 10th College of Pharmacy Research Day Virtual Platform(idea, supervision, content creator, design), College of Pharmacy, King Saud University (2021) https://coprd10.vfairs.com/